Clinical Trial Update: Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy [NA]

View source ↗

Summary

A pilot open-label clinical trial is evaluating resistant potato starch for patients with cirrhosis and overt hepatic encephalopathy and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatic Encephalopathy

Drugs mentioned

• Resistant Potato Starch (Resistant potato starch)

Snippet

Sponsor: Mayo Clinic | Conditions: Hepatic Encephalopathy, Cirrhosis | NA | Status: RECRUITING